Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a light cap boost brain power after injury?

NCT ID NCT06956404

Recruiting now Symptom relief Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether shining a special light on the forehead (transcranial photobiomodulation) can improve blood flow and thinking in older adults who had a traumatic brain injury 1-2 years ago. Seventy people aged 55-85 will receive either real or sham light therapy for about 12 minutes a day, three times a week, for six weeks. Researchers will measure changes in brain blood flow using MRI and test thinking skills like memory and attention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial photobiomodulation (tPBM) device
What this could lead to
If it works, this could point toward a non-invasive way to improve thinking and brain blood flow in older adults after a traumatic brain injury.
What could go wrong
This is an early-stage study with only 70 people. It tests a device, not a drug, and the benefits may be small or not last long. Side effects are possible but expected to be mild.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRAUMATIC BRAIN INJURY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.